Home Cart 0 Sign in  
X

[ CAS No. 771-50-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 771-50-6
Chemical Structure| 771-50-6
Chemical Structure| 771-50-6
Structure of 771-50-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 771-50-6 ]

Related Doc. of [ 771-50-6 ]

Alternatived Products of [ 771-50-6 ]

Product Details of [ 771-50-6 ]

CAS No. :771-50-6 MDL No. :MFCD00005624
Formula : C9H7NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KMAKOBLIOCQGJP-UHFFFAOYSA-N
M.W : 161.16 Pubchem ID :69867
Synonyms :
I3CA;ICOOH;β-Indolylcarboxylic Acid;Indole-β-carboxylic Acid
Chemical Name :1H-Indole-3-carboxylic acid

Calculated chemistry of [ 771-50-6 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.26
TPSA : 53.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.0
Log Po/w (XLOGP3) : 1.99
Log Po/w (WLOGP) : 1.87
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 1.89
Consensus Log Po/w : 1.56

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.58
Solubility : 0.422 mg/ml ; 0.00262 mol/l
Class : Soluble
Log S (Ali) : -2.73
Solubility : 0.299 mg/ml ; 0.00186 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.65
Solubility : 0.364 mg/ml ; 0.00226 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.08

Safety of [ 771-50-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 771-50-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 771-50-6 ]
  • Downstream synthetic route of [ 771-50-6 ]

[ 771-50-6 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 771-50-6 ]
  • [ 1670-85-5 ]
Reference: [1] Helvetica Chimica Acta, 1994, vol. 77, # 7, p. 1886 - 1894
[2] Phytochemistry, 2000, vol. 53, # 1, p. 59 - 69
[3] Journal of the Chemical Society, 1956, p. 2853,2856
[4] Journal of Pharmaceutical and Biomedical Analysis, 2016, vol. 120, p. 419 - 424
[5] Patent: EP1932833, 2008, A1,
  • 2
  • [ 392-12-1 ]
  • [ 7664-41-7 ]
  • [ 67-63-0 ]
  • [ 771-50-6 ]
  • [ 87-51-4 ]
  • [ 879-37-8 ]
  • [ 3050-37-1 ]
Reference: [1] Biochemical Journal, 1958, vol. 69, p. 22 P
  • 3
  • [ 771-50-6 ]
  • [ 101774-27-0 ]
YieldReaction ConditionsOperation in experiment
60% With bromine In acetic acid at 20℃; Step 8; 6-bromo-indole-3-carboxylic acid; <n="62"/>Bromine (49.58g, 3100mmol) is added slowly to a white suspension of Indole-3- carboxylic acid (50 g, 3 lOmmol) in 50OmL of acetic acid at room temperature, and the mixture is stirred at room temperature overnight. The solid formed is filtered and dried under vacuum for 3 hours to afford 45 g of the title compound as a grey solid (60percent). MS (m/e): 240 (M+ 1)
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 24, p. 9768 - 9772
[2] Patent: WO2009/12125, 2009, A1, . Location in patent: Page/Page column 60-61
  • 4
  • [ 771-50-6 ]
  • [ 15317-58-5 ]
YieldReaction ConditionsOperation in experiment
77% With thionyl chloride; hydrazine In benzene C.
Indole-3-Hydrazide
A three neck round bottom flask fitted with a condenser with argon outlet, addition funnel, and argon inlet, was oven dried at 132° C. for 2h, then heat dried while purging with argon.
The apparatus was allowed to cool to room temperature under argon then charged with 500mL benzene via oven dried syringe, followed by 3.0g indole-3-carboxylic acid (18.6 mMol).
The solid was insoluble at room temperature. 5.5 mL thionyl chloride was added (74.4mMol, 4.0 eq) slowly via the addition funnel.
The resulting solution was refluxed overnight, at which time all the solid had dissolved.
The reaction mixture was cooled to ambient temperature and 4.6mL anhydrous hydrazine (148.8 mMol, 8 eq.) was added.
A precipitate immediately formed, which was filtered and dried under reduced pressure overnight.
The pure hydrazide was obtained by normal phase column chromatography, using a mixture of 9:1 methylene chloride:methanol (77percent yield).
Product Analysis: NMR (d6 DMSO)--carbonyl carbon 165.1 ppm. aromatic and vinyl carbons 135.9, 127.0, 126.1, 121.7, 120.8, 120.2, 111.7, 108.9 ppm.
Elemental analysis (C9 H9 N30); Calculated: C 61.71, H 5.14, N 24.00. Found: C 61.51; H 5.03; N 24.23.
Reference: [1] Patent: US5338843, 1994, A,
[2] Journal of the Chemical Society, 1956, p. 2853,2856
[3] Patent: WO2008/118745, 2008, A1, . Location in patent: Page/Page column 35
[4] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 1, p. 212 - 215
[5] European Journal of Medicinal Chemistry, 2012, vol. 55, p. 432 - 438
[6] ChemMedChem, 2012, vol. 7, # 11, p. 1915 - 1920
[7] ChemMedChem, 2013, vol. 8, # 9, p. 1468 - 1474
[8] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 630 - 635
[9] Journal of Chemical Research, 2015, vol. 39, # 5, p. 296 - 299
[10] Biochemistry, 2016, vol. 55, # 21, p. 3020 - 3035
[11] Pharmazie, 2017, vol. 72, # 12, p. 707 - 713
  • 5
  • [ 771-50-6 ]
  • [ 39891-70-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 12, p. 3713 - 3716
[2] Tetrahedron Asymmetry, 2010, vol. 21, # 18, p. 2307 - 2313
  • 6
  • [ 771-50-6 ]
  • [ 100-39-0 ]
  • [ 27018-76-4 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.5 h;
Stage #2: for 1 h;
1-benzyl-1H-indole-3-carboxylic acid; To a stirred solution of 0.50 g (3.10 mmol) 1H-indole-3-carboxylic acid in 5 ml DMF was added 0.27 g (6.75 mmol) of NaH (60percent in oil). The mixture was stirred at RT for 30 min. and then 0.39 ml (3.28 mmol) of benzyl bromid was added. The mixture was stirred an additional hour and then poured onto water and extracted with ethyl acetate. The combined organic phases were dried over Na2SO4 and concentrated in vacuo. Crystallization in Et2O afforded 0.61 g (78percent) of 1-benzyl-1H-indole-3-carboxylic acid as a white solid. ES-MS m/e (percent): 250 (M-H+).
72% With sodium hydride In N,N-dimethyl-formamide at 20℃; 1 H-indole-3-carboxylic acid (2.5 g)In DMF (25 mL) was added 60percent sodium hydride (1.4 g)After stirring at room temperature for 40 minutes,Benzyl bromide 2.0 mL) was added dropwise,And the mixture was stirred at room temperature for 19 hours. Water (10 mL) was added to the reaction solution, and the mixture was extracted with ethyl acetate. The obtained aqueous layer was made acidic, extracted with ethyl acetate, and washed with saturated brine.The organic layer was dried over sodium sulfate,Crystals obtained by distilling off the solvent under reduced pressure were crystallized fromWashed with ethanol to obtain 2.8 g (yield 72percent) of 1-benzyl-1 H-indole-3-carboxylic acid.
Reference: [1] Patent: US2007/21463, 2007, A1, . Location in patent: Page/Page column 17
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 2, p. 785 - 800
[3] Patent: JP2017/171619, 2017, A, . Location in patent: Paragraph 0122; 0123
  • 7
  • [ 771-50-6 ]
  • [ 100-44-7 ]
  • [ 27018-76-4 ]
Reference: [1] Journal of the Chinese Chemical Society, 2008, vol. 55, # 5, p. 1160 - 1165
  • 8
  • [ 771-50-6 ]
  • [ 27018-76-4 ]
Reference: [1] Pharmazie, 2002, vol. 57, # 4, p. 238 - 242
[2] MedChemComm, 2016, vol. 7, # 9, p. 1759 - 1767
  • 9
  • [ 771-50-6 ]
  • [ 95-51-2 ]
  • [ 61788-27-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 21, p. 6122 - 6126
  • 10
  • [ 771-50-6 ]
  • [ 226883-79-0 ]
Reference: [1] Pharmazie, 2002, vol. 57, # 4, p. 238 - 242
  • 11
  • [ 771-50-6 ]
  • [ 868656-97-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 24, p. 9768 - 9772
  • 12
  • [ 771-50-6 ]
  • [ 110-53-2 ]
  • [ 727421-73-0 ]
YieldReaction ConditionsOperation in experiment
49% With sodium hydride In hexane; water; ethyl acetate; N,N-dimethyl-formamide Example-14
Preparation of 3-carboxy-1-pentyl-1H-indole (Hapten-C)
Indole 3-carboxylic acid (3 g, 18.62 mmol) was added to a suspension of sodium hydride (60percent in oil) (1.11 g, 1.5 eq) in dry DMF (30 ml) under a nitrogen atmosphere.
The mixture was stirred at room temperature for 45 min (H2 evolving has ceased) and to this was added 1-bromopentane (4.62 ml, 2 eq) in dry DMF (10 ml) dropwise.
The mixture was stirred at room temperature overnight.
The solvents were removed in vacuo and to the residue was added water (30 ml) and ethyl acetate (30 ml).
The ethyl acetate portion was separated, dried over sodium sulphate, filtered and evaporated to dryness.
The crude residue was purified by column chromatography (silica gel:
20percent ethyl acetate in hexane) to give the title compound (2.12 g, 49percent) as a cream solid.
49%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.75 h; Inert atmosphere
Stage #2: at 20℃;
Indole 3-carboxylic acid (3g, 18.62mmol) was added to a suspension of sodium hydride (60percent in oil) (1.11g, 1.5eq) in dry DMF (30ml) under a nitrogen atmosphere.
The mixture was stirred at room temperature for 45 min (H2 evolving has ceased) and to this was added 1-bromopentane (4.62ml, 2eq) in dry DMF (10ml) dropwise.
The mixture was stirred at room temperature overnight.
The solvents were removed in vacuo and to the residue was added water (30ml) and ethyl acetate (30ml).
The ethyl acetate portion was separated, dried over sodium sulphate, filtered and evaporated to dryness.
The crude residue was purified by column chromatography (silica gel:
20percent ethyl acetate in hexane) to give the title compound (2.12g, 49percent) as a cream solid.
Reference: [1] Patent: US2012/208213, 2012, A1,
[2] Patent: EP2487155, 2012, A1, . Location in patent: Page/Page column 10
[3] Patent: EP2698385, 2014, A1, . Location in patent: Page/Page column
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 771-50-6 ]

Carboxylic Acids

Chemical Structure| 858515-65-8

[ 858515-65-8 ]

4-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.98

Chemical Structure| 32387-21-6

[ 32387-21-6 ]

1-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.95

Chemical Structure| 2124-55-2

[ 2124-55-2 ]

Indole-4-carboxylic acid

Similarity: 0.93

Chemical Structure| 1159511-18-8

[ 1159511-18-8 ]

3-Methyl-1H-indole-4-carboxylic acid

Similarity: 0.91

Chemical Structure| 174500-88-0

[ 174500-88-0 ]

6-Cyano-1H-indole-3-carboxylic acid

Similarity: 0.90

Related Parent Nucleus of
[ 771-50-6 ]

Indoles

Chemical Structure| 858515-65-8

[ 858515-65-8 ]

4-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.98

Chemical Structure| 32387-21-6

[ 32387-21-6 ]

1-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.95

Chemical Structure| 227960-12-5

[ 227960-12-5 ]

Methyl 5-methylindole-3-carboxylate

Similarity: 0.93

Chemical Structure| 942-24-5

[ 942-24-5 ]

Methyl indole-3-carboxylate

Similarity: 0.93

Chemical Structure| 686747-19-3

[ 686747-19-3 ]

Methyl 5-amino-1H-indole-3-carboxylate

Similarity: 0.93